Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
115Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $5.44M | $-12.15M | $-1.14 |
| 2024 | $4.02M | $-19.12M | $-3.12 |
| 2023 | $3.92M | $-13.81M | $-3.42 |
| 2022 | $5.12M | $-12.85M | $-3.18 |
| 2021 | $4.34M | $-15.31M | $-5.40 |
Social Signal Score
Earnings
Fri, Aug 28(in 12 days)
Consensus estimate $-0.12 per share
Typical surprise +51.7% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Feb 25$-0.38 vs $-0.23miss
- Thu, Aug 28$-0.40 vs $-0.43beat
- Fri, Feb 28$-0.00 vs $-0.53beat
- Thu, Aug 29$-0.00 vs $-0.05beat
Estimates and results for ATHE via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
ATHEhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (1)
- Newsglobenewswire.com·3d ago·Positive
Alterity Therapeutics Announces Granting of New U.S. Composition of Matter Patent for ATH434 – Newly granted patent extends protection for ATH434 to at least 2045, significantly enhancing its strategic value and long-term commercial potential –
View source ↗